122 related articles for article (PubMed ID: 22921906)
21. Protection of halogenated DNA from strand breakage and sister-chromatid exchange induced by the topoisomerase I inhibitor camptothecin.
Orta ML; Mateos S; Cantero G; Wolff LJ; Cortés F
Mutat Res; 2008 Jan; 637(1-2):40-8. PubMed ID: 17706727
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin-induced endoreduplication in CHO cells: DNA damage and inhibition of topoisomerase II.
Cantero G; Pastor N; Mateos S; Campanella C; Cortés F
Mutat Res; 2006 Jul; 599(1-2):160-6. PubMed ID: 16574165
[TBL] [Abstract][Full Text] [Related]
23. Dominant lethal mutations of topoisomerase II inhibitors etoposide and merbarone in male mice: a mechanistic study.
Attia SM
Arch Toxicol; 2012 May; 86(5):725-31. PubMed ID: 22207148
[TBL] [Abstract][Full Text] [Related]
24. Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage.
Fortune JM; Osheroff N
J Biol Chem; 1998 Jul; 273(28):17643-50. PubMed ID: 9651360
[TBL] [Abstract][Full Text] [Related]
25. Emodin triggers DNA double-strand breaks by stabilizing topoisomerase II-DNA cleavage complexes and by inhibiting ATP hydrolysis of topoisomerase II.
Li Y; Luan Y; Qi X; Li M; Gong L; Xue X; Wu X; Wu Y; Chen M; Xing G; Yao J; Ren J
Toxicol Sci; 2010 Dec; 118(2):435-43. PubMed ID: 20855424
[TBL] [Abstract][Full Text] [Related]
26. A novel use for the comet assay: detection of topoisomerase II inhibitors.
Salti GI; Das Gupta TK; Constantinou AI
Anticancer Res; 2000; 20(5A):3189-93. PubMed ID: 11062742
[TBL] [Abstract][Full Text] [Related]
27. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
Adlakha RC; Ashorn CL; Chan D; Zwelling LA
Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251
[TBL] [Abstract][Full Text] [Related]
28. The DNA demethylating 5-azaC induces endoreduplication in cultured Chinese hamster cells.
Mateos S; Domínguez I; Pastor N; Cantero G; Cortés F
Mutat Res; 2005 Oct; 578(1-2):33-42. PubMed ID: 16202795
[TBL] [Abstract][Full Text] [Related]
29. DNA damage signals induction of fas ligand in tumor cells.
Mo YY; Beck WT
Mol Pharmacol; 1999 Feb; 55(2):216-22. PubMed ID: 9927611
[TBL] [Abstract][Full Text] [Related]
30. Evidence for the participation of topoisomerases I and II in cadmium-induced metallothionein expression in Chinese hamster ovary cells.
Mattern MR; Tan KB; Zimmerman JP; Mong SM; Bartus JO; Hofmann GA; Drake FH; Johnson RK; Crooke ST; Mirabelli CK
Anticancer Drug Des; 1989 Aug; 4(2):107-24. PubMed ID: 2478139
[TBL] [Abstract][Full Text] [Related]
31. Merbarone induces activation of caspase-activated DNase and excision of chromosomal DNA loops from the nuclear matrix.
Otake Y; Mims A; Fernandes DJ
Mol Pharmacol; 2006 Apr; 69(4):1477-85. PubMed ID: 16434617
[TBL] [Abstract][Full Text] [Related]
32. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells.
Sullivan DM; Latham MD; Ross WE
Cancer Res; 1987 Aug; 47(15):3973-9. PubMed ID: 3038304
[TBL] [Abstract][Full Text] [Related]
33. A novel peroxisome proliferator-activated receptor alpha/gamma agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells.
Kao YH; Hsieh HP; Chitlimalla SK; Pan WY; Kuo CC; Tsai YC; Lin WH; Chuang SE; Chang JY
Anticancer Drugs; 2008 Feb; 19(2):151-8. PubMed ID: 18176111
[TBL] [Abstract][Full Text] [Related]
34. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells.
Snyder RD
Environ Mol Mutagen; 2000; 35(1):13-21. PubMed ID: 10692223
[TBL] [Abstract][Full Text] [Related]
35. High yield of endoreduplication induced by ICRF-193: a topoisomerase II catalytic inhibitor.
Pastor N; José Flores M; Domínguez I; Mateos S; Cortés F
Mutat Res; 2002 Apr; 516(1-2):113-20. PubMed ID: 11943617
[TBL] [Abstract][Full Text] [Related]
36. Effects of the DNA topoisomerase II inhibitor merbarone in male mouse meiotic divisions in vivo: cell cycle arrest and induction of aneuploidy.
Kallio M; Lähdetie J
Environ Mol Mutagen; 1997; 29(1):16-27. PubMed ID: 9020303
[TBL] [Abstract][Full Text] [Related]
37. Efficient induction of chromosome-type aberrations by topoisomerase II inhibitors closely associated with stabilization of the cleavable complex in cultured fibroblastic cells.
Suzuki H; Ikeda T; Yamagishi T; Nakaike S; Nakane S; Ohsawa M
Mutat Res; 1995 May; 328(2):151-61. PubMed ID: 7739599
[TBL] [Abstract][Full Text] [Related]
38. Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex.
Constantinou AI; Husband A
Anticancer Res; 2002; 22(5):2581-5. PubMed ID: 12529967
[TBL] [Abstract][Full Text] [Related]
39. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
40. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
